Plante Moran Financial Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-37
Closed -$7.64K 772
2025
Q4
$7.64K Hold
37
﹤0.01% 597
2025
Q3
$6.63K Hold
37
﹤0.01% 590
2025
Q2
$5.97K Hold
37
﹤0.01% 620
2025
Q1
$6.29K Hold
37
﹤0.01% 626
2024
Q4
$6.15K Hold
37
﹤0.01% 656
2024
Q3
$6.36K Hold
37
﹤0.01% 654
2024
Q2
$5.7K Hold
37
﹤0.01% 641
2024
Q1
$5.69K Hold
37
﹤0.01% 680
2023
Q4
$5.85K Hold
37
﹤0.01% 631
2023
Q3
$5.42K Hold
37
﹤0.01% 596
2023
Q2
$5.67K Hold
37
﹤0.01% 623
2023
Q1
$5.74K Hold
37
﹤0.01% 635
2022
Q4
$5.7K Buy
+37
New +$5.46K ﹤0.01% 658
2019
Q1
Sell
-20
Closed -$2K 825
2018
Q4
$2K Buy
+20
New +$2.73K ﹤0.01% 708
2016
Q2
Sell
-64
Closed -$6K 911
2016
Q1
$6K Buy
+64
New +$5.64K ﹤0.01% 550

Other funds holding FBT

Plante Moran Financial Advisors's FBT Position: Q1 2026 in Review

Plante Moran Financial Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2026, closing a stake of 37 shares — an estimated $7.64K sold.

Plante Moran Financial Advisors first reported a position in FBT in Q1 2016 and held it in 15 quarters. The position peaked at $7.64K in Q4 2025. 308 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Plante Moran Financial Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2026 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 37 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $7.64K.
  • Plante Moran Financial Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2016 and held it in 15 quarters.
  • Plante Moran Financial Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $7.64K in Q4 2025.
  • 308 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.